Chemoresistance and the Self-Maintaining Tumor Microenvironment
Open accessThe DOI matches its Crossref record; 245 of the 245 references it cites were found in a registry or an index.
Abstract
The progression of cancer is associated with alterations in the tumor microenvironment, including changes in extracellular matrix (ECM) composition, matrix rigidity, hypervascularization, hypoxia, and paracrine factors. One key malignant phenotype of cancer cells is their ability to resist chemotherapeutics, and elements of the ECM can promote chemoresistance in cancer cells through a variety of signaling pathways, inducing changes in gene expression and protein activity that allow resistance. Furthermore, the ECM is maintained as an environment that facilitates chemoresistance, since its constitution modulates the phenotype of cancer-associated cells, which themselves affect the microenvironment. In this review, we discuss how the properties of the tumor microenvironment promote chemoresistance in cancer cells, and the interplay between these external stimuli. We focus on both the response of cancer cells to the external environment, as well as the maintenance of the external environment, and how a chemoresistant phenotype emerges from the complex signaling network present.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Gilkes, D. M., Bajpai, S., Chaturvedi, P., Wirtz, D., & Semenza, G. L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.442939 · Cited by 467 · cited 3×
“The secretion of the molecules TGF-β, VEGF, FGF, PDGF, TNF-α, IL-1, and IL-8 by macrophages is increased following hypoxia [206].”
BackgroundRetractedZhang, X., Li, Y., Ma, Y., Yang, L., Wang, T., Meng, X., Zong, Z., Sun, X., Hua, X., & Li, H. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0892-2 · Cited by 234 · cited 13×
“VEGF is a target for anti-angiogenic therapeutics, which aim to decrease the vasculature to provide an environment that is less suitable for tumor progression.”
BackgroundInfluentialRetractedYousif, N. G. (2014) · Cell Biology International · doi:10.1002/cbin.10184 · Cited by 109 · cited 1×
“Similarly, fibronectin has been observed to promote oncogenic pathways in cancer cells, including MAPK [127], PI3K [128], and YAP [129].”
BackgroundRetractedZhang, Y., Zhang, Y., Geng, L., Yi, H., Huo, W., Talmon, G. A., Kim, Y. C., Wang, S. M., & Wang, J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.713735 · Cited by 40 · cited 1×
“Furthermore, TGF-β has been shown to mediate the activation of pyruvate dehydrogenase kinase 4 (PDK4) by 5-fluorouracil [183], and the activation of PDK4 leads to colorectal cancer cells that are highly chemoresistant.”
BackgroundRetractedMolecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091 · cited 5×
“, the loss of tight junctions, adherens junctions, desmosomes, and gap junctions [16].”
BackgroundInfluentialMolecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Role of YAP/TAZ in mechanotransduction
Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., et al. (2011) · Nature · doi:10.1038/nature10137 · Cited by 5,979 · cited 1×
“YAP is a mechanoresponsive transcriptional regulator, with external stiffness promoting its activation and translocation to the nucleus [149], and this localization occurs concurrently with EMT induction in response to stiffness [146].”
BackgroundMatrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kessenbrock, K., Plaks, V., & Werb, Z. (2010) · Cell · doi:10.1016/j.cell.2010.03.015 · Cited by 5,151 · cited 14×
“MMPs enhance tumor invasion by allowing cells to degrade the matrix around them to facilitate invasion [48].”
BackgroundInfluentialAccessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632 · cited 1×
“Growth factors such as epidermal growth factors (EGFs), fibroblast growth factors (FGFs), platelet derived growth factor (PDGF), and hepatocyte growth factor (HGF) are highly abundant in the tumor environment [55].”
BackgroundRemodelling the extracellular matrix in development and disease
Bonnans, C., Chou, J., & Werb, Z. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3904 · Cited by 4,367 · cited 2×
“Remodeling of the ECM by secreted matrix metalloproteinases can promote the release of growth factors sequestered in the ECM such as TGF-β [56,57].”
BackgroundMatrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101 · cited 2×
“PI3K signaling lies downstream of focal adhesion formation, and is known to be activated with high matrix stiffness [50].”
BackgroundTensional homeostasis and the malignant phenotype
Paszek, M. J., Zahir, N., Johnson, K. R., Lakins, J. N., Rozenberg, G. I., Gefen, A., Reinhart-King, C. A., Margulies, S. S., Dembo, M., Boettiger, D., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.010 · Cited by 3,941 · cited 1×
“Additionally, cross talk occurs between the MAPK cascade and the Rho/ROCK/myosin axis to enhance both these pathways [154].”
BackgroundRGD AND OTHER RECOGNITION SEQUENCES FOR INTEGRINS
Ruoslahti, E. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.697 · Cited by 3,191 · cited 1×
“Integrins interact with the tripeptide Arg-Gly-Asp (RGD) binding site, which is present in collagen, fibronectin, laminin, and other ECM proteins such as tenascin [46].”
BackgroundOlive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170 · cited 1×
“In pancreatic cancer, drug delivery is impaired due to the abnormal vasculature, and has been studied in vivo using autofluorescent drugs such as doxorubicin for visualization [187].”
BackgroundThe complexity of NF-κB signaling in inflammation and cancer
Hoesel, B., & Schmid, J. A. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-86 · Cited by 3,165 · cited 1×
“NF-κB can further be activated through a non-canonical pathway in response to multiple receptors, such as the BAFF receptor [181].”
BackgroundThe extracellular matrix: A dynamic niche in cancer progression
Lu, P., Weaver, V. M., & Werb, Z. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201102147 · Cited by 3,024
TGF-β-induced epithelial to mesenchymal transition
Xu, J., Lamouille, S., & Derynck, R. (2009) · Cell Research · doi:10.1038/cr.2009.5 · Cited by 2,804
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797 · cited 1×
“MMPs further release VEGF sequestered in the ECM to promote vascularization [232], and the deposition of high amounts of ECM proteins contributes to interstitial fluid pressure, as negatively charged hyaluronan chains promote the immobilization of liquid [233].”
BackgroundDrug resistance in cancer: An overview
Housman, G., Byler, S., Heerboth, S., Lapinska, K., Longacre, M., Snyder, N., & Sarkar, S. (2014) · Cancers · doi:10.3390/cancers6031769 · Cited by 2,463 · cited 1×
“The resistance of cancer cells to chemotherapeutics emerges from a reduction in drug availability, and an induction of EMT and oncogenic signaling pathways [243].”
BackgroundRoles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
McCubrey, J. A., Steelman, L. S., Chappell, W. H., Abrams, S. L., Wong, E. W. T., Chang, F., Lehmann, B., Terrian, D. M., Milella, M., Tafuri, A., et al. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.10.001 · Cited by 2,284 · cited 1×
“Bcl-2 is a target protein of chemotherapeutics such as paclitaxel [27].”
BackgroundHigh Interstitial Fluid Pressure - an Obstacle in Cancer Therapy
Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1456 · Cited by 2,222 · cited 1×
“Since large molecular weight compounds rely on convection for transport, drug efficiency is reduced [185,186].”
BackgroundYu, Q., & Stamenkovic, I. (2000) · PubMed Central · Cited by 2,203
Noman, M. Z., Desantis, G., Janji, B., Hasmim, M., Karray, S., Dessen, P., Bronte, V., & Chouaib, S. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20131916 · Cited by 2,166 · cited 1×
“This upregulation suppresses the activation of cytotoxic T cells, and hence promotes immune response evasion [219].”
BackgroundRevisiting STAT3 signalling in cancer: new and unexpected biological functions
Yu, H., Lee, H., Herrmann, A., Buettner, R., & Jove, R. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3818 · Cited by 2,137 · cited 1×
“Another oncogenic signaling pathway effector is the signal transducer and activator of transcription 3 (STAT3), which forms a homodimer in its phosphorylated state, allowing it to translocate into the nucleus and promote cell survival and oncogenic transformation [33].”
BackgroundThe role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy
Muz, B., de la Puente, P., Azab, F., & Azab, A. K. (2015) · Hypoxia · doi:10.2147/hp.s93413 · Cited by 2,066 · cited 2×
“When these hyperproliferative cancer cells surpass their blood supply, they show an increased consumption of oxygen and nutrients, further contributing to an increasing hypoxic microenvironment in a vicious cycle [38].”
BackgroundZheng, X., Carstens, J. L., Kim, J., Scheible, M., Kaye, J., Sugimoto, H., Wu, C.-C., LeBleu, V. S., & Kalluri, R. (2015) · Nature · doi:10.1038/nature16064 · Cited by 2,032 · cited 1×
“EMT has been further demonstrated to promote chemoresistance to both the DNA alkylating agent cyclophosphamide and the DNA synthesis inhibitor gemcitabine, as loss of either Snail or Twist enhances chemosensitivity [23,24].”
BackgroundThe Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
Mendoza, M. C., Er, E. E., & Blenis, J. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.03.006 · Cited by 1,817 · cited 1×
“Many signaling pathways, such as the mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K) pathways, promote cell proliferation and survival [25].”
BackgroundFischer, K. R., Durrans, A., Lee, S., Sheng, J., Li, F., Wong, S. T. C., Choi, H., El Rayes, T., Ryu, S., Troeger, J., et al. (2015) · Nature · doi:10.1038/nature15748 · Cited by 1,791 · cited 1×
“EMT has been further demonstrated to promote chemoresistance to both the DNA alkylating agent cyclophosphamide and the DNA synthesis inhibitor gemcitabine, as loss of either Snail or Twist enhances chemosensitivity [23,24].”
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
Balkwill, F., Charles, K. A., & Mantovani, A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.013 · Cited by 1,769 · cited 1×
“Chronic inflammation, which occurs with extended upregulation of the inflammatory response, involves various cytokines and growth factors secreted by infiltrating immune cells [64].”
BackgroundChronic inflammation and cytokines in the tumor microenvironment
Landskron, G., De la Fuente, M., Thuwajit, P., Thuwajit, C., & Hermoso, M. A. (2014) · Journal of Immunology Research · doi:10.1155/2014/149185 · Cited by 1,765 · cited 4×
“Interleukin-10, upregulated during chronic inflammation, also activates STAT3 and leads to Bcl-2 upregulation [65].”
BackgroundInfluentialYu, Q., & Stamenkovic, I. (2000) · Genes & Development · doi:10.1101/gad.14.2.163 · Cited by 1,754
Non-Smad pathways in TGF-β signaling
Zhang, Y. E. (2009) · Cell Research · doi:10.1038/cr.2008.328 · Cited by 1,749
Tumor angiogenesis: molecular pathways and therapeutic targets
Weis, S. M., & Cheresh, D. A. (2011) · Nature Medicine · doi:10.1038/nm.2537 · Cited by 1,736 · cited 13×
“VEGF is a target for anti-angiogenic therapeutics, which aim to decrease the vasculature to provide an environment that is less suitable for tumor progression.”
BackgroundInfluential(1989) · PubMed · Cited by 1,639
Cox, T. R., & Erler, J. T. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.004077 · Cited by 1,569 · cited 1×
“This fibrotic stroma is abundant in ECM proteins, and it also shows an increased degree of stiffness compared to a healthy stroma, promoting mechanosignaling [3].”
BackgroundVEGF and the quest for tumour angiogenesis factors
Ferrara, N. (2002) · Nature Reviews Cancer · doi:10.1038/nrc909 · Cited by 1,536 · cited 13×
“VEGF is a target for anti-angiogenic therapeutics, which aim to decrease the vasculature to provide an environment that is less suitable for tumor progression.”
BackgroundInfluentialCalvo, F., Ege, N., Grande-Garcia, A., Hooper, S., Jenkins, R. P., Chaudhry, S. I., Harrington, K., Williamson, P., Moeendarbary, E., Charras, G., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2756 · Cited by 1,478
Nishida, N., Yano, H., Nishida, T., Kamura, T., & Kojiro, M. (2006) · Vascular Health and Risk Management · doi:10.2147/vhrm.2006.2.3.213 · Cited by 1,434 · cited 13×
“VEGF is a target for anti-angiogenic therapeutics, which aim to decrease the vasculature to provide an environment that is less suitable for tumor progression.”
BackgroundInfluentialCreighton, C. J., Li, X., Landis, M., Dixon, J. M., Neumeister, V. M., Sjolund, A., Rimm, D. L., Wong, H., Rodriguez, A., Herschkowitz, J. I., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905718106 · Cited by 1,412 · cited 1×
“Mesenchymal breast cancer cells have been shown to have a higher resistance to docetaxel [20], and the inhibition of EMT by miR-760 in breast cancer leads to doxorubicin chemosensitivity [21].”
BackgroundDirect regulation of TWIST by HIF-1α promotes metastasis
Yang, M.-H., Wu, M.-Z., Chiou, S.-H., Chen, P.-M., Chang, S.-Y., Liu, C.-J., Teng, S.-C., & Wu, K.-J. (2008) · Nature Cell Biology · doi:10.1038/ncb1691 · Cited by 1,345 · cited 8×
“This increased Twist expression also leads to IL-6 production by the breast cancer cells [171].”
BackgroundInfluentialRac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability
Radisky, D. C., Levy, D. D., Littlepage, L. E., Liu, H., Nelson, C. M., Fata, J. E., Leake, D., Godden, E. L., Albertson, D. G., Angela Nieto, M., et al. (2005) · Nature · doi:10.1038/nature03688 · Cited by 1,284 · cited 1×
“MMP-3 can promote Snail expression via the production of reactive oxygen species [119].”
BackgroundTGFβ signalling: a complex web in cancer progression
Ikushima, H., & Miyazono, K. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2853 · Cited by 1,173 · cited 1×
“TGF-β is a particularly interesting signaling molecule, as it has been reported to have both pro-apoptotic and pro-survival effects on cancer cells, depending on the context [58].”
BackgroundRole of extracellular matrix assembly in interstitial transport in solid tumors.
Netti, P. A., Berk, D. A., Swartz, M. A., Grodzinsky, A. J., & Jain, R. K. (2000) · PubMed · Cited by 1,165
Regulation of matrix biology by matrix metalloproteinases
Mott, J. D., & Werb, Z. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.07.010 · Cited by 1,104 · cited 1×
“MMPs can release fragments from ECM proteins that regulate cell growth, though details on the intracellular signaling pathways through which these effects are achieved are limited [133].”
BackgroundChauhan, V. P., Martin, J. D., Liu, H., Lacorre, D. A., Jain, S. R., Kozin, S. V., Stylianopoulos, T., Mousa, A. S., Han, X., Adstamongkonkul, P., et al. (2013) · Nature Communications · doi:10.1038/ncomms3516 · Cited by 1,031 · cited 1×
“The disruption of solid stress within the microenvironment by various inhibitors has been shown to improve vascular perfusion and therefore drug delivery [142,143].”
BackgroundTen years of anti-vascular endothelial growth factor therapy
Ferrara, N., & Adamis, A. P. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.17 · Cited by 1,030 · cited 1×
“VEGF, which can promote PI3K and MAPK kinase signaling [134], is released from heparan sulfate proteoglycans in the ECM by MMP-9 and MMP-2 [135].”
BackgroundMultidrug resistance (MDR) in cancer
Krishna, R., & Mayer, L. D. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00114-7 · Cited by 1,026
The hypoxic tumour microenvironment
Petrova, V., Annicchiarico-Petruzzelli, M., Melino, G., & Amelio, I. (2018) · Oncogenesis · doi:10.1038/s41389-017-0011-9 · Cited by 1,019
ABC transporters in cancer: more than just drug efflux pumps
Fletcher, J. I., Haber, M., Henderson, M. J., & Norris, M. D. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2789 · Cited by 1,018 · cited 1×
“As the largest family of transmembrane proteins, the normal function of ABC transporters is to shuttle lipids, metabolic products, and foreign substances out of the cells [13].”
BackgroundTargeting TGF-β Signaling in Cancer
Colak, S., & ten Dijke, P. (2017) · Trends in cancer · doi:10.1016/j.trecan.2016.11.008 · Cited by 1,003
Sever, R., & Brugge, J. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006098 · Cited by 989 · cited 1×
“ECM protein engagement with integrins promotes progression through the cell cycle, activating the PI3K and MAPK pathways, as well as the activation of other effectors such as c-Jun [120].”
BackgroundWei, S. C., Fattet, L., Tsai, J. H., Guo, Y., Pai, V. H., Majeski, H. E., Chen, A. C., Sah, R. L., Taylor, S. S., Engler, A. J., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3157 · Cited by 948 · cited 1×
“Mechanotransduction of a stiff environment promotes the activity of the transcription factor Twist in breast cancer cells [144].”
BackgroundSerine phosphorylation of STATs
Decker, T., & Kovarik, P. (2000) · Oncogene · doi:10.1038/sj.onc.1203481 · Cited by 887
(2002) · PubMed · Cited by 840
TNF-α/NF-κB/Snail pathway in cancer cell migration and invasion
Wu, Y., & Zhou, B. P. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605530 · Cited by 798
Weaver, V. M., Lelièvre, S., Lakins, J. N., Chrenek, M. A., Jones, J. C. R., Giancotti, F., Werb, Z., & Bissell, M. J. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00125-3 · Cited by 793
A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis
Adorno, M., Cordenonsi, M., Montagner, M., Dupont, S., Wong, C., Hann, B., Solari, A., Bobisse, S., Rondina, M. B., Guzzardo, V., et al. (2009) · Cell · doi:10.1016/j.cell.2009.01.039 · Cited by 782
Wheelock, M. J., Shintani, Y., Maeda, M., Fukumoto, Y., & Johnson, K. R. (2008) · Journal of Cell Science · doi:10.1242/jcs.000455 · Cited by 767
Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells
Sullivan, N. J., Sasser, A. K., Axel, A. E., Vesuna, F., Raman, V, Ramirez, N., Oberyszyn, T. M., & Hall, B. M. (2009) · Oncogene · doi:10.1038/onc.2009.180 · Cited by 757 · cited 1×
“This increased Twist expression also leads to IL-6 production by the breast cancer cells [171].”
BackgroundHeerboth, S., Housman, G., Leary, M., Longacre, M., Byler, S., Lapinska, K., Willbanks, A., & Sarkar, S. (2015) · Clinical and Translational Medicine · doi:10.1186/s40169-015-0048-3 · Cited by 739 · cited 1×
“MMPs enhance tumor invasion by allowing cells to degrade the matrix around them to facilitate invasion [48].”
BackgroundCarcinoma-associated fibroblasts: orchestrating the composition of malignancy
Gascard, P., & Tlsty, T. D. (2016) · Genes & Development · doi:10.1101/gad.279737.116 · Cited by 732 · cited 1×
“CAF heterogeneity leads to variance in the effect of these cells on cancer cells, which can be anti- or pro-tumorigenic [204].”
BackgroundRegulation of hypoxia-inducible factor-1α by NF-κB
van Uden, P., Kenneth, N. S., & Rocha, S. (2008) · Biochemical Journal · doi:10.1042/bj20080476 · Cited by 729
Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1
Noë, V., Fingleton, B., Jacobs, K., Crawford, H. C., Vermeulen, S., Steelant, W., Bruyneel, E., Matrisian, L. M., & Mareel, M. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.1.111 · Cited by 695
The two faces of IL-6 in the tumor microenvironment
Fisher, D. T., Appenheimer, M. M., & Evans, S. S. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.01.008 · Cited by 693 · cited 1×
“IL-6, secreted from stromal cells including tumor-associated macrophages and T cells [170], can promote EMT in breast cancer cells, with the induction of vimentin, N-cadherin, Snail, and Twist.”
BackgroundActivin Receptor-like Kinase (ALK)1 Is an Antagonistic Mediator of Lateral TGFβ/ALK5 Signaling
Goumans, M.-J., Valdimarsdottir, G., Itoh, S., Lebrin, F., Larsson, J., Mummery, C., Karlsson, S., & ten Dijke, P. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00386-1 · Cited by 689 · cited 1×
“TGF-β is one of these factors, and it also promotes the expression of other angiogenic factors (FGF, VEGF, CXCL12 and PDGF-C) in endothelial cells [234,235].”
BackgroundRac and Rho GTPases in cancer cell motility control
Parri, M., & Chiarugi, P. (2010) · Cell Communication and Signaling · doi:10.1186/1478-811x-8-23 · Cited by 639
Lo, H.-W., Hsu, S.-C., Xia, W., Cao, X., Shih, J.-Y., Wei, Y., Abbruzzese, J. L., Hortobagyi, G. N., & Hung, M.-C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0575 · Cited by 625 · cited 8×
“This increased Twist expression also leads to IL-6 production by the breast cancer cells [171].”
BackgroundInfluentialThe molecular mechanisms of chemoresistance in cancers
Zheng, H.-C. (2017) · Oncotarget · doi:10.18632/oncotarget.19048 · Cited by 624 · cited 3×
“These mechanisms are made up of a diverse set of signaling pathways, which can be activated by a wealth of stimuli to promote chemoresistance [1,2].”
BackgroundAsati, V., Mahapatra, D. K., & Bharti, S. K. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.01.012 · Cited by 612 · cited 1×
“Both of these cascades involve transduction through the regulatory phosphorylation of multiple effector proteins, which promotes cell survival gene expression and inhibits apoptosis [26].”
BackgroundSiemann, D. W. (2011) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.05.001 · Cited by 611 · cited 1×
“Collectively, this causes diminished blood flow and an inadequate supply of nutrients and oxygen [70].”
BackgroundCrawford, Y., Kasman, I., Yu, L., Zhong, C., Wu, X., Modrusan, Z., Kaminker, J., & Ferrara, N. (2009) · Cancer Cell · doi:10.1016/j.ccr.2008.12.004 · Cited by 611 · cited 1×
“In one demonstrated mechanism, CAFs upregulate PDGF, which leads to cancer cell growth [72].”
BackgroundThe role of p53 in cancer drug resistance and targeted chemotherapy
Hientz, K., Mohr, A., Bhakta-Guha, D., & Efferth, T. (2017) · Oncotarget · doi:10.18632/oncotarget.13475 · Cited by 587 · cited 1×
“A commonly mutated cell cycle and DNA damage response protein, p53, has been shown to promote resistance to cisplatin, doxorubicin, gemcitabine, and tamoxifen in its mutated and inactivated state [36], and is known to be overactivated in CSCs [8].”
BackgroundTumour vascularization: sprouting angiogenesis and beyond
Hillen, F., & Griffioen, A. W. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9094-7 · Cited by 583 · cited 1×
“VEGF promotes the vasodilation of existing vessels and enhances vessel wall permeability, as well as promoting the expression of MMPs that enable the ECM remodeling required for new vessels to form [236].”
BackgroundStylianopoulos, T., Munn, L. L., & Jain, R. K. (2018) · Trends in Cancer · doi:10.1016/j.trecan.2018.02.005 · Cited by 563 · cited 1×
“Since large molecular weight compounds rely on convection for transport, drug efficiency is reduced [185,186].”
BackgroundErdogan, B., & Webb, D. J. (2017) · Biochemical Society Transactions · doi:10.1042/bst20160387 · Cited by 558 · cited 3×
“As well as the many other paracrine factors secreted by fibroblasts, including HGH, FGF, and C-C motif chemokine ligand 5 (CCL5), activated fibroblasts are more contractile, and therefore they promote force-mediated ECM remodeling, altering the ECM composition to facilitate cancer cell invasion and chemoresistance [63…”
BackgroundInfluentialShields, J. D., Fleury, M. E., Yong, C., Tomei, A. A., Randolph, G. J., & Swartz, M. A. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.04.020 · Cited by 552 · cited 2×
“The increased pressure is also suggested to promote the presence of chemokine gradients, facilitating chemotaxis through oncogenic signaling pathways [195].”
BackgroundClinical significance of macrophage heterogeneity in human malignant tumors
Komohara, Y., Jinushi, M., & Takeya, M. (2014) · Cancer Science · doi:10.1111/cas.12314 · Cited by 551 · cited 1×
“Macrophages can be divided into two types, which can either promote or inhibit the inflammatory response [205].”
BackgroundSamuel, M. S., Lopez, J. I., McGhee, E. J., Croft, D. R., Strachan, D., Timpson, P., Munro, J., Schröder, E., Zhou, J., Brunton, V. G., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.05.008 · Cited by 541
Rice, A. J., Cortes, E., Lachowski, D., Cheung, B. C. H., Karim, S. A., Morton, J. P., & del Río Hernández, A. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.54 · Cited by 523 · cited 2×
“YAP is a mechanoresponsive transcriptional regulator, with external stiffness promoting its activation and translocation to the nucleus [149], and this localization occurs concurrently with EMT induction in response to stiffness [146].”
BackgroundSelf-citationThe distribution of the anticancer drug Doxorubicin in relation to blood vessels in solid tumors
Primeau, A. J., Rendon, A., Hedley, D., Lilge, L., & Tannock, I. F. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1664 · Cited by 499 · cited 1×
“It was shown that doxorubicin was only detectable near to blood vessels, and not detectable in hypoxic regions [189].”
BackgroundProvenzano, P. P., & Keely, P. J. (2011) · Journal of Cell Science · doi:10.1242/jcs.067009 · Cited by 494 · cited 1×
“FAK can also promote cell cycle progression in response to stiffness, through the activation of the MAPK cascade [153].”
BackgroundHepatic Stellate Cells and Liver Fibrosis
Moreira, R. K. (2007) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2007-131-1728-hscalf · Cited by 452
Hypoxia inducible factors in cancer stem cells
Heddleston, J. M., Li, Z., Lathia, J. D., Bao, S., Hjelmeland, A. B., & Rich, J. N. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605551 · Cited by 452 · cited 1×
“Through PI3K, NF-κB, and Wnt signaling, as well as signaling pathways involving Notch and Oct4, hypoxia can also promote CSC self-renewal [96,97].”
BackgroundLewis, A. M., Varghese, S., Xu, H., & Alexander, H. R. (2006) · Journal of Translational Medicine · doi:10.1186/1479-5876-4-48 · Cited by 443
Stylianopoulos, T., Poh, M.-Z., Insin, N., Bawendi, M. G., Fukumura, D., Munn, L. L., & Jain, R. K. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2010.06.016 · Cited by 443 · cited 2×
“In diffusion, drug molecules perform a random walk by Brownian motion, affected by steric, hydrodynamic, and electrostatic interactions [10].”
BackgroundCancer stem cells and chemoresistance: The smartest survives the raid
Zhao, J. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.02.008 · Cited by 437 · cited 10×
“Metastatic relapse after chemotherapy is suggested to be due to therapeutic resistance occurring specifically in CSCs, as their evasion from apoptosis allows the tumor to re-develop after therapy has concluded [8].”
BackgroundInfluentialLiver stiffness: a novel parameter for the diagnosis of liver disease
Mueller, S. (2010) · Hepatic Medicine: Evidence and Research · doi:10.2147/hmer.s7394 · Cited by 434
Leight, J. L., Wozniak, M. A., Chen, S., Lynch, M. L., & Chen, C. S. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-06-0537 · Cited by 425 · cited 2×
“Matrix rigidity has also been shown to switch the response of cells to TGF-β, with a soft environment showing TGF-β-induced apoptosis and a stiff environment showing TGF-β-induced EMT [62].”
BackgroundAdhesion to fibronectin regulates Hippo signaling via the FAK–Src–PI3K pathway
Kim, N.-G., & Gumbiner, B. M. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201501025 · Cited by 421 · cited 12×
“Activation of this pathway involves the dephosphorylation of Yes-associated protein (YAP), allowing it to translocate to the nucleus and promote the expression of proliferation genes.”
BackgroundInfluentialProteolysis of Latent Transforming Growth Factor-β (TGF-β)-binding Protein-1 by Osteoclasts
Dallas, S. L., Rosser, J. L., Mundy, G. R., & Bonewald, L. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111663200 · Cited by 414
Fernando, R. I., Castillo, M. D., Litzinger, M., Hamilton, D. H., & Palena, C. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0156 · Cited by 400 · cited 1×
“Interleukin-8 (IL-8), secreted by tumor cells and affecting adjacent tumor cells, has also been shown to promote EMT [172].”
BackgroundThe Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer
Senthebane, D. A., Rowe, A., Thomford, N. E., Shipanga, H., Munro, D., Mazeedi, M. A. M. A., Almazyadi, H. A. M., Kallmeyer, K., Dandara, C., Pepper, M. S., et al. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071586 · Cited by 399 · cited 1×
“These mechanisms are made up of a diverse set of signaling pathways, which can be activated by a wealth of stimuli to promote chemoresistance [1,2].”
BackgroundTissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression
Mouw, J. K., Yui, Y., Damiano, L., Bainer, R. O., Lakins, J. N., Acerbi, I., Ou, G., Wijekoon, A. C., Levental, K. R., Gilbert, P. M., et al. (2014) · Nature Medicine · doi:10.1038/nm.3497 · Cited by 396 · cited 1×
“The microRNA miR-18a is upregulated in mammary epithelial cells in response to stiffness, and it inhibits the activity of phosphatase and tensin homologue (PTEN), a negative regulator of the PI3K pathway [151].”
BackgroundGraham, T. R., Zhau, H. E., Odero-Marah, V. A., Osunkoya, A. O., Kimbro, K. S., Tighiouart, M., Liu, T., Simons, J. W., & O'Regan, R. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2559 · Cited by 384 · cited 1×
“Similarly, IGF1 acts through the MAPK cascade in prostate cancer cells to upregulate ZEB1 expression [167], but through the NF-κB pathway in mammary epithelial cells to upregulate Snail expression [168].”
BackgroundLi, Y., Ahmed, F., Ali, S., Philip, P. A., Kucuk, O., & Sarkar, F. H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4604 · Cited by 376 · cited 1×
“The DNA replication inhibitor cisplatin promotes NF-κB binding to DNA, a process that reduces the efficiency of cisplatin-induced apoptosis [30].”
BackgroundBelotti, D., Paganoni, P., Manenti, L., Garofalo, A., Marchini, S., Taraboletti, G., & Giavazzi, R. (2003) · PubMed · Cited by 374
MAPK Signaling Up-regulates the Activity of Hypoxia-inducible Factors by Its Effects on p300
Sang, N., Stiehl, D. P., Bohensky, J., Leshchinsky, I., Srinivas, V., & Caro, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209702200 · Cited by 370 · cited 1×
“The expression of HIF-1α is also upregulated by NF-κB signaling, as well as by PI3K and MAPK signaling [1,91,92].”
BackgroundHepatocyte growth factor induces cell scattering through MAPK/Egr‐1‐mediated upregulation of Snail
Grotegut, S., von Schweinitz, D., Christofori, G., & Lehembre, F. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601213 · Cited by 363 · cited 1×
“HGF upregulates the expression of Snail through the MAPK cascade, which recruits the transcription factor early growth response 1 (EGR1) to the Snail promoter [166].”
BackgroundInterstitial fluid flow induces myofibroblast differentiation and collagen alignment in vitro
Ng, C. P., Hinz, B., & Swartz, M. A. (2005) · Journal of Cell Science · doi:10.1242/jcs.02605 · Cited by 360 · cited 1×
“IFP can also directly lead to some alignment of the matrix [240].”
BackgroundTumor hypoxia: A target for selective cancer therapy
Kizaka‐Kondoh, S., Inoue, M., Harada, H., & Hiraoka, M. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01395.x · Cited by 352 · cited 1×
“Since many chemotherapeutics target highly proliferating cells, drug efficacy is reduced in the presence of low oxygen [80].”
BackgroundSenger, D. R., & Davis, G. E. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005090 · Cited by 349
Barriers to drug delivery in solid tumors
Sriraman, S. K., Aryasomayajula, B., & Torchilin, V. P. (2014) · Tissue Barriers · doi:10.4161/tisb.29528 · Cited by 338 · cited 1×
“This acidic environment can lead to drugs becoming electrostatically charged, limiting their ability to cross the hydrophobic plasma membrane [74].”
BackgroundInteraction of tumor cells with the microenvironment
Ungefroren, H., Sebens, S., Seidl, D., Lehnert, H., & Hass, R. (2011) · Cell Communication and Signaling · doi:10.1186/1478-811x-9-18 · Cited by 333
McMahon, S., Charbonneau, M., Grandmont, S., Richard, D. E., & Dubois, C. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604507200 · Cited by 330
Mechanotransduction in tumor progression: The dark side of the force
Broders-Bondon, F., Nguyen Ho-Bouldoires, T. H., Fernandez-Sanchez, M.-E., & Farge, E. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201701039 · Cited by 319 · cited 1×
“Furthermore, the increased IFP caused by hypervascularization, combined with the excess of ECM molecules, leads to the compression of blood vessels to further limit oxygen transport to the tumor [239].”
BackgroundPathways mediating VEGF-independent tumor angiogenesis
Ferrara, N. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.11.003 · Cited by 313 · cited 1×
“Furthermore, PDGF can promote the proliferation and migration of these endothelial and smooth muscle cells [238].”
BackgroundChemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis
Vyas, D., Laput, G., & Vyas, A. (2014) · OncoTargets and Therapy · doi:10.2147/ott.s60114 · Cited by 310 · cited 10×
“This increased Twist expression also leads to IL-6 production by the breast cancer cells [171].”
BackgroundInfluentialWikström, P., Stattin, P., Franck-Lissbrant, I., Damber, J.-E., & Bergh, A. (1998) · The Prostate · doi:10.1002/(sici)1097-0045(19980915)37:1<19::aid-pros4>3.0.co;2-3 · Cited by 307 · cited 1×
“For example, TGF-β has been reported to promote apoptosis in prostate cancer cells [59] but it has also been associated with metastasis and poor clinical outcome in prostate cancer [60].”
BackgroundIoachim, E., Charchanti, A., Briasoulis, E., Karavasilis, V, Tsanou, H., Arvanitis, D. L., Agnantis, N. J., & Pavlidis, N. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00210-1 · Cited by 301 · cited 1×
“Levels of fibronectin and tenascin are correlated with breast cancer progression and negatively correlated with survival rate [45].”
BackgroundThe Warburg effect and drug resistance
Bhattacharya, B., Mohd Omar, M. F., & Soong, R. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13422 · Cited by 298 · cited 1×
“, the release of cytochrome c from the mitochondria [99].”
BackgroundTargeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy
Godwin, P., Baird, A. M., Heavey, S., Barr, M. P., O’Byrne, K. J., & Gately, K. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00120 · Cited by 296
Koren, E., Apte, A., Jani, A., & Torchilin, V. P. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.002 · Cited by 293 · cited 1×
“For example, drugs have been developed that are activated only in an oxygen-deprived environment [244,245].”
BackgroundYang, L., Lin, C., & Liu, Z.-R. (2006) · Cell · doi:10.1016/j.cell.2006.08.036 · Cited by 288 · cited 1×
“PDGF is able to induce β-catenin nuclear localization to promote EMT [169].”
BackgroundWartenberg, M., Ling, F. C., Müschen, M., Klein, F., Acker, H., Gassmann, M., Petrat, K., Pütz, V., Hescheler, J., & Sauer, H. (2003) · The FASEB Journal · doi:10.1096/fj.02-0358fje · Cited by 287 · cited 1×
“HIF-1α-mediated upregulation of P-glycoprotein has been further observed in prostate multicellular tumor spheroids [79].”
BackgroundPAK1 phosphorylation of MEK1 regulates fibronectin-stimulated MAPK activation
Slack-Davis, J. K., Eblen, S. T., Zecevic, M., Boerner, S. A., Tarcsafalvi, A., Diaz, H. B., Marshall, M. S., Weber, M. J., Parsons, J. T., & Catling, A. D. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200212141 · Cited by 279 · cited 1×
“Similarly, fibronectin has been observed to promote oncogenic pathways in cancer cells, including MAPK [127], PI3K [128], and YAP [129].”
BackgroundKoenig, A., Mueller, C., Hasel, C., Adler, G., & Menke, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2804 · Cited by 277 · cited 1×
“The interaction of collagen type I with either α1β1 or α2β1 integrins leads to the disruption of E-cadherin complexes and subsequent nuclear localization of β-catenin [113].”
BackgroundChronopoulos, A., Robinson, B., Sarper, M., Cortes, E., Auernheimer, V., Lachowski, D., Attwood, S., García, R., Ghassemi, S., Fabry, B., et al. (2016) · Nature Communications · doi:10.1038/ncomms12630 · Cited by 274 · cited 1×
“An alternative approach is to target cancer-associated fibroblasts in addition to targeting cancer cells directly, and research into this possibility has been performed [246,247].”
BackgroundSelf-citation(2003) · PubMed · Cited by 272
The Extracellular Matrix and Pancreatic Cancer: A Complex Relationship
Weniger, M., Honselmann, K., & Liss, A. (2018) · Cancers · doi:10.3390/cancers10090316 · Cited by 268 · cited 1×
“The physical barrier of the ECM impedes drug access to tumors, as the dense fibrotic ECM impairs the ability of drugs to diffuse from blood vessels to cancer cells [103].”
BackgroundHypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase
Ma, B., Chen, Y., Chen, L., Cheng, H., Mu, C., Li, J., Gao, R., Zhou, C., Cao, L., Liu, J., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3073 · Cited by 266 · cited 1×
“Hypoxia further promotes the activity of a ubiquitin ligase, which inhibits LATS1/2 and therefore promotes YAP nuclear localization [95].”
BackgroundMechanotransduction of fluid stresses governs 3D cell migration
Polacheck, W. J., German, A. E., Mammoto, A., Ingber, D. E., & Kamm, R. D. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1316848111 · Cited by 265 · cited 1×
“Furthermore, IFP can activate β1 integrin, leading to the activation of FAK, and the upregulation of cell migration [201].”
BackgroundZhang, W., Shi, X., Peng, Y., Wu, M., Zhang, P., Xie, R., Wu, Y., Yan, Q., Liu, S., & Wang, J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0129603 · Cited by 261 · cited 2×
“Hypoxia and EMT The expression of proteins that regulate EMT is affected by HIF-1α, most notably, the transcription factors ZEB-1, Snail, Slug, Smad-interacting protein 1 (Sip1) and Twist [81–83].”
BackgroundSignalling pathways linking integrins with cell cycle progression
Moreno-Layseca, P., & Streuli, C. H. (2014) · Matrix Biology · doi:10.1016/j.matbio.2013.10.011 · Cited by 260 · cited 1×
“This integrin–ECM interaction is also involved in cross-talk with paracrine factor receptor signaling to facilitate cell proliferation [121].”
BackgroundShintani, Y., Maeda, M., Chaika, N., Johnson, K. R., & Wheelock, M. J. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0071oc · Cited by 259 · cited 1×
“Through integrin binding, collagen I has also been shown to promote TGF-β3 autocrine signaling in lung cancer cells, which promotes EMT [114].”
BackgroundRiol-Blanco, L., Sánchez-Sánchez, N., Torres, A., Tejedor, A., Narumiya, S., Corbí, A. L., Sánchez-Mateos, P., & Rodríguez-Fernández, J. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.7.4070 · Cited by 257 · cited 1×
“This chemokine receptor known to promote PI3K, Rho, and MAPK signaling [196] and therefore, interstitial pressure is likely to play a role in promoting oncogenic signaling in this manner.”
BackgroundLoss of FOXA1/2 Is Essential for the Epithelial-to-Mesenchymal Transition in Pancreatic Cancer
Song, Y., Washington, M. K., & Crawford, H. C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2979 · Cited by 256 · cited 1×
“Furthermore, forkhead box (FOX) transcription factors, associated with EMT, promote expression of the intermediate filament protein vimentin [19].”
BackgroundKoike, T., Kimura, N., Miyazaki, K., Yabuta, T., Kumamoto, K., Takenoshita, S., Chen, J., Kobayashi, M., Hosokawa, M., Taniguchi, A., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402088101 · Cited by 245 · cited 1×
“molecule syndecan-4, in colon cancer cells [214].”
Cancer Associated Fibroblasts: The Architects of Stroma Remodeling
Santi, A., Kugeratski, F. G., & Zanivan, S. (2018) · PROTEOMICS · doi:10.1002/pmic.201700167 · Cited by 244 · cited 1×
“CAFs secrete high levels of ECM proteins, as well as paracrine factors for the cancer cells, promoting a dense and stiff fibrotic environment [202].”
BackgroundSullivan, R., Paré, G. C., Frederiksen, L. J., Semenza, G. L., & Graham, C. H. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0198 · Cited by 243 · cited 1×
“This complex then activates downstream signaling [40,41].”
Kim, H.-J., Litzenburger, B. C., Cui, X., Delgado, D. A., Grabiner, B. C., Lin, X., Lewis, M. T., Gottardis, M. M., Wong, T. W., Attar, R. M., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01315-06 · Cited by 241 · cited 1×
“Similarly, IGF1 acts through the MAPK cascade in prostate cancer cells to upregulate ZEB1 expression [167], but through the NF-κB pathway in mammary epithelial cells to upregulate Snail expression [168].”
BackgroundMammary epithelial cell interactions with fibronectin stimulate epithelial-mesenchymal transition
Park, J., & Schwarzbauer, J. E. (2014) · Oncogene · doi:10.1038/onc.2013.118 · Cited by 240 · cited 4×
“MMP-2, 9 and 14 are all able to cleave the latent TGF-β binding protein (LTBP), and therefore release TGF-β.”
BackgroundInfluentialRizvi, I., Gurkan, U. A., Tasoglu, S., Alagic, N., Celli, J. P., Mensah, L. B., Mai, Z., Demirci, U., & Hasan, T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216989110 · Cited by 234 · cited 1×
“EMT has been observed in response to shear stress, generated by IFP, in cells from laryngeal squamous cell carcinoma [192] and ovarian cancer [193].”
BackgroundStudebaker, A. W., Storci, G., Werbeck, J. L., Sansone, P., Sasser, A. K., Tavolari, S., Huang, T., Chan, M. W. Y., Marini, F. C., Rosol, T. J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0400 · Cited by 229 · cited 1×
“Breast cancer growth and invasion has also been shown to be sensitive to IL-6 through chronic STAT3 activation [174].”
BackgroundEdlund, S., Bu, S., Schuster, N., Aspenström, P., Heuchel, R., Heldin, N.-E., ten Dijke, P., Heldin, C.-H., & Landström, M. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.02-03-0037 · Cited by 226
Extracellular Matrix, a Hard Player in Angiogenesis
Mongiat, M., Andreuzzi, E., Tarticchio, G., & Paulitti, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111822 · Cited by 223 · cited 1×
“The collagen XVIII fragment endostatin is anti-angiogenic, whereas laminins promote endothelial cell tip formation and thus promote angiogenesis [230].”
BackgroundHIF‐1α and CA IX staining in invasive breast carcinomas: Prognosis and treatment outcome
Trastour, C., Benizri, E., Ettore, F., Ramaioli, A., Chamorey, E., Pouysségur, J., & Berra, E. (2007) · International Journal of Cancer · doi:10.1002/ijc.22436 · Cited by 222
Weaver, V. M., Lelièvre, S. A., Lakins, J. N., Chrenek, M. A., Jones, J., Giancotti, F. G., Werb, Z., & Bissell, M. J. (2002) · University of North Texas Digital Library (University of North Texas) · doi:10.1016/s1535-6108%2802%2900125-3 · Cited by 208
Pun, S. H., Tack, F., Bellocq, N. C., Cheng, J., Grubbs, B. H., Jensen, G. S., Davis, M. E., Brewster, M., Janicot, M., Janssens, B., et al. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.7.918 · Cited by 201 · cited 1×
“Further studies have shown that nanoparticles cannot efficiently penetrate into tumors, and they instead become localized in peripheral regions [105,106].”
BackgroundHypoxia Increases Resistance of Human Pancreatic Cancer Cells to Apoptosis Induced by Gemcitabine
Yokoi, K., & Fidler, I. J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0488 · Cited by 199 · cited 1×
“Activation of these pathways by hypoxia has been shown to decrease gemcitabine sensitivity, with resistance being primarily induced by PI3K and NF-κB signaling, and only partially through MAPK signaling [93].”
BackgroundMolecular Pathways: Regulation and Therapeutic Implications of Multidrug Resistance
Chen, K. G., & Sikic, B. I. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1590 · Cited by 197
Câmara, J., & Jarai, G. (2010) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-3-2 · Cited by 192
Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology
Xue, X., & Liang, X.-J. (2012) · Chinese Journal of Cancer · doi:10.5732/cjc.011.10326 · Cited by 187 · cited 1×
“This shuttling occurs through an ATP-dependent conformational change that moves substances to the outside of the cell [14].”
BackgroundHIF‐1 and p53: communication of transcription factors under hypoxia
Schmid, T., Zhou, J., & Brüne, B. (2004) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2004.tb00467.x · Cited by 186 · cited 1×
“In the long-term hypoxic state, p53 accumulates and promotes HIF-1α degradation, and therefore, apoptosis [101].”
BackgroundUnderwood, T. J., Hayden, A. L., Derouet, M., Garcia, E., Noble, F., White, M. J., Thirdborough, S., Mead, A., Clemons, N., Mellone, M., et al. (2015) · The Journal of Pathology · doi:10.1002/path.4467 · Cited by 186 · cited 1×
“Additionally, periostin has also been shown to activate PI3K signaling in esophageal cancer, acting through αvβ3 and αvβ5 integrins [132], and hyaluronan in the ECM can promote CSC self-renewal by interacting with the protein CD44, which is present on the surface of CSCs [8].”
BackgroundBao, B., Azmi, A. S., Ali, S., Ahmad, A., Li, Y., Banerjee, S., Kong, D., & Sarkar, F. H. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.04.008 · Cited by 180 · cited 1×
“Through PI3K, NF-κB, and Wnt signaling, as well as signaling pathways involving Notch and Oct4, hypoxia can also promote CSC self-renewal [96,97].”
BackgroundJanuchowski, R., Świerczewska, M., Sterzyńska, K., Wojtowicz, K., Nowicki, M., & Zabel, M. (2016) · Journal of Cancer · doi:10.7150/jca.15371 · Cited by 179 · cited 1×
“Upregulation of collagen expression has been shown to promote resistance to many common therapeutics in ovarian cancer cells [222].”
BackgroundTumor Cell Invasion Is Promoted by Interstitial Flow-Induced Matrix Priming by Stromal Fibroblasts
Shieh, A. C., Rozansky, H. A., Hinz, B., & Swartz, M. A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1513 · Cited by 177 · cited 2×
“IFP promotes release of TGF-β from the LTBP complex, activating fibroblasts, which then reorganize collagen fibers to promote cancer cell invasion [199].”
BackgroundStromal Modulators of TGF-β in Cancer
Costanza, B., Umelo, I., Bellier, J., Castronovo, V., & Turtoi, A. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6010007 · Cited by 177
Tumoral Drug Metabolism: Overview and Its Implications for Cancer Therapy
Michael, M., & Doherty, M. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.120 · Cited by 177 · cited 2×
“Enzymes from these families metabolize commonly used chemotherapeutics such as tamoxifen, paclitaxel, and all-trans retinoic acid [12].”
BackgroundInterstitial Flow in a 3D Microenvironment Increases Glioma Invasion by a CXCR4-Dependent Mechanism
Munson, J. M., Bellamkonda, R. V., & Swartz, M. A. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2838 · Cited by 176 · cited 2×
“CXCR4 signaling, as well as MAPK signaling, has been observed in hepatocellular carcinoma cells in response to IFP [198].”
BackgroundThe Role of NF‐κB in Hypoxia‐Induced Gene Expression
Taylor, C. T., & Cummins, E. P. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05024.x · Cited by 175
FAK controls the mechanical activation of YAP, a transcriptional regulator required for durotaxis
Lachowski, D., Cortes, E., Robinson, B., Rice, A., Rombouts, K., & Del Río Hernández, A. E. (2018) · The FASEB Journal · doi:10.1096/fj.201700721r · Cited by 175 · cited 2×
“As cells accumulate in this fibrotic region, and become activated by mechanotransduction, rigidity is further increased by the ECM remodeling activity of these cells [54,225].”
BackgroundSelf-citationKrstic, J., & Santibanez, J. F. (2014) · The Scientific World Journal · doi:10.1155/2014/521754 · Cited by 174
Hypoxia, Snail and incomplete epithelial–mesenchymal transition in breast cancer
Lundgren, K., Nordenskjöld, B., & Landberg, G. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605369 · Cited by 171 · cited 1×
“Interestingly, one study on breast cancer cells indicated that although Snail upregulation under hypoxic conditions limited the effects of the chemotherapeutic tamoxifen, it did not promote a full transition from the epithelial to the mesenchymal phenotype [87].”
BackgroundQiao, Y., Zhang, C., Li, A., Wang, D., Luo, Z., Ping, Y., Zhou, B., Liu, S., Li, H., Yue, D., et al. (2018) · Oncogene · doi:10.1038/onc.2017.387 · Cited by 166 · cited 1×
“This receptor is activated by the chemokine CXCL12, which is overexpressed in tumors, and promotes cell survival [173].”
BackgroundOverexpression of MMP-9 and HIF-1α in Breast Cancer Cells under Hypoxic Conditions
Choi, J. Y., Jang, Y. S., Min, S. Y., & Song, J. Y. (2011) · Journal of Breast Cancer · doi:10.4048/jbc.2011.14.2.88 · Cited by 164 · cited 1×
“In addition to collagen and fibronectin modulation, hypoxia can promote ECM degradation and remodeling by upregulating the expression of MMPs, with MMP-2 upregulation observed in pancreatic cancer [208], and MMP-9 expression observed in breast cancer [209] in response to low oxygen.”
BackgroundNagaharu, K., Zhang, X., Yoshida, T., Katoh, D., Hanamura, N., Kozuka, Y., Ogawa, T., Shiraishi, T., & Imanaka‐Yoshida, K. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.10.015 · Cited by 162 · cited 1×
“Tenascin C has also been shown to promote delocalization of E-cadherin from the membrane, and therefore β-catenin activation, through the tyrosine kinase Src [117].”
BackgroundGonzales, M., Haan, K. M., Baker, S., Fitchmun, M. I., Todorov, I., Weitzman, S. A., & Jones, J. C. R. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.2.259 · Cited by 162 · cited 1×
“The basement membrane protein laminin-1 has been shown to act through the β4 integrin to activate the NF-κB pathway in breast cancer [130], and laminin-5 is known to promote the MAPK pathway through binding to α3β1 integrin [131].”
BackgroundAutologous Morphogen Gradients by Subtle Interstitial Flow and Matrix Interactions
Fleury, M. E., Boardman, K. C., & Swartz, M. A. (2006) · Biophysical Journal · doi:10.1529/biophysj.105.080192 · Cited by 161 · cited 1×
“Interstitial pressure can alter the gradients of various soluble factors such as chemokines [242], and this may lead to the upregulation of paracrine signaling, that induces cancer cell chemoresistance.”
BackgroundStéphanou, A., McDougall, S. R., Anderson, A. R. A., & Chaplain, M. A. J. (2005) · Mathematical and Computer Modelling · doi:10.1016/j.mcm.2005.05.008 · Cited by 160 · cited 1×
“Furthermore, mathematical modelling of the effect of blood vessel architecture on drug delivery to tumors has suggested that the excess of vessel connectivity decreases the ability of drugs to exit the vasculature [188].”
BackgroundClinical Advances of Hypoxia-Activated Prodrugs in Combination With Radiation Therapy
Mistry, I. N., Thomas, M., Calder, E. D. D., Conway, S. J., & Hammond, E. M. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.03.024 · Cited by 154 · cited 1×
“For example, drugs have been developed that are activated only in an oxygen-deprived environment [244,245].”
BackgroundHypoxia induces hexokinase II gene expression in human lung cell line A549
Riddle, S. R., Ahmad, A., Ahmad, S., Deeb, S. S., Malkki, M., Schneider, B. K., Allen, C. B., & White, C. W. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.278.2.l407 · Cited by 154 · cited 1×
“Hexokinase 2 is a rate-limiting enzyme in glycolysis known to be upregulated via HIF-1α [98], and it can promote a drug-resistant phenotype by inhibiting aspects of apoptosis, e.”
BackgroundPredicting bulk mechanical properties of cellularized collagen gels using multiphoton microscopy
Raub, C. B., Putnam, A. J., Tromberg, B. J., & George, S. C. (2010) · Acta Biomaterialia · doi:10.1016/j.actbio.2010.07.004 · Cited by 150 · cited 1×
“For example, collagen abundance and crosslinking both contribute to an increased rigidity [220], and the presence of MMPs regulates the structure and stiffness of the ECM [57].”
BackgroundInfluence of low pH on cytotoxicity of paclitaxel, mitoxantrone and topotecan
Vukovic, V, & Tannock, I. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.201 · Cited by 148
Ju, J. A., Godet, I., Ye, I. C., Byun, J., Jayatilaka, H., Lee, S. J., Xiang, L., Samanta, D., Lee, M., Wu, P.-H., et al. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0338 · Cited by 143
Rho kinase proteins--pleiotropic modulators of cell survival and apoptosis.
Street, C. A., & Bryan, B. A. (2011) · PubMed · Cited by 143
Regulation of the multidrug resistance genes by stress signals.
Sukhai, M. A., & Piquette‐Miller, M. (2000) · PubMed · Cited by 143
Yang, H., Guan, L., Li, S., Jiang, Y., Xiong, N., Li, L., Wu, C., Zeng, H., & Liu, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.7583 · Cited by 143 · cited 1×
“Another mechanism for PI3K activation is through caveolin-1, a structural component of caveolar membrane domains, which is mechanosensitive to shear stress and promotes PI3K signaling in breast carcinoma cells [152].”
BackgroundCha, B., Geng, X., Mahamud, M. R., Fu, J., Mukherjee, A., Kim, Y., Jho, E.-H., Kim, T. H., Kahn, M. L., Xia, L., et al. (2016) · Genes & Development · doi:10.1101/gad.282400.116 · Cited by 141 · cited 1×
“For example, the PI3K/Akt and Wnt/β-catenin pathways have been associated with regulating transcription of the MDR1 gene [139], as well as being responsive to mechanical stimuli [140,141].”
BackgroundVoutouri, C., Polydorou, C., Papageorgis, P., Gkretsi, V., & Stylianopoulos, T. (2016) · Neoplasia · doi:10.1016/j.neo.2016.10.001 · Cited by 139 · cited 1×
“MMPs further release VEGF sequestered in the ECM to promote vascularization [232], and the deposition of high amounts of ECM proteins contributes to interstitial fluid pressure, as negatively charged hyaluronan chains promote the immobilization of liquid [233].”
BackgroundHypoxia, drug therapy and toxicity
Lee, K., Roth, R. A., & LaPres, J. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.08.001 · Cited by 138 · cited 1×
“Conversely, low oxygen can decrease the catalytic ability of cytochrome P450, and hence promote drug retention [77].”
BackgroundHypoxia-induced chemoresistance in cancer cells: The role of not only HIF-1
Doktorová, H., Hraběta, J., Khalil, M. A., & Eckschlager, T. (2015) · Biomedical Papers · doi:10.5507/bp.2015.025 · Cited by 138 · cited 1×
“This is due to the high consumption of oxygen by rapidly proliferating cells, and a poorly formed vasculature that does not provide enough additional oxygen [37].”
BackgroundAzimi, I., Petersen, R. M., Thompson, E. W., Roberts-Thomson, S. J., & Monteith, G. R. (2017) · Scientific Reports · doi:10.1038/s41598-017-15474-7 · Cited by 137 · cited 1×
“Hypoxia has been shown in breast cancer cells to lead to the production of reactive oxygen species (ROS), which can promote EMT [211].”
BackgroundThe Role of Tumor Microenvironment in Chemoresistance: 3D Extracellular Matrices as Accomplices
Senthebane, D., Jonker, T., Rowe, A., Thomford, N., Munro, D., Dandara, C., Wonkam, A., Govender, D., Calder, B., Soares, N., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102861 · Cited by 131 · cited 1×
“Multiple ECM proteins affect oncogenic signaling pathways within cancer cells [123].”
BackgroundLi, W., & Melton, D. W. (2011) · Oncogene · doi:10.1038/onc.2011.426 · Cited by 131 · cited 1×
“Overexpression of ERCC1, a protein involved in nucleotide excision repair and downstream of the MAPK pathway, is linked to a poor outcome for melanoma patients treated with platinum-based chemotherapy [35].”
BackgroundExtracellular matrix proteins regulate epithelial–mesenchymal transition in mammary epithelial cells
Chen, Q. K., Lee, K.-A., Radisky, D. C., & Nelson, C. M. (2013) · Differentiation · doi:10.1016/j.diff.2013.03.003 · Cited by 131 · cited 1×
“Laminin-111, present in the basement membrane that separates epithelial cells from the underlying stroma, suppresses the EMT response through the α6 integrin subunit [115].”
BackgroundFunction of cancer cell-derived extracellular matrix in tumor progression
Xiong, G.-F., & Xu, R. (2016) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2016.08 · Cited by 128 · cited 1×
“Other key ECM proteins that are upregulated in cancer include fibronectin, laminin, and tenascin [44].”
BackgroundKai, A. K., Chan, L. K., Lo, R. C., Lee, J. M., Wong, C. C., Wong, J. C., & Ng, I. O. (2016) · Hepatology · doi:10.1002/hep.28577 · Cited by 128 · cited 1×
“The MMP inhibitor TIMP-2 has been shown to be downregulated in response to HIF-1α upregulation in hepatocellular carcinoma [210], indicating the multifaceted regulation of MMP activity in response to oxygen levels.”
BackgroundLi, C., Yang, D., Cao, X., Wang, F., Hong, D.-Y., Wang, J., Shen, X., & Chen, Y. (2017) · Oncology Letters · doi:10.3892/ol.2017.5896 · Cited by 128 · cited 1×
“Investigations into the mechanism of fibronectin-induced EMT have revealed that fibronectin can potentiate TGF-β signaling through Smad3/4 [110] and that the cysteine protease calpain is required for fibronectin to induce EMT [111].”
BackgroundTato-Costa, J., Casimiro, S., Pacheco, T. R., Pires, R., Fernandes, A., Alho, I., Pereira, P., Costa, P., Castelo, H. B., Ferreira, J. A., et al. (2015) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2015.09.003 · Cited by 126 · cited 1×
“This contributes to the pro-tumor inflammatory microenvironment [67].”
BackgroundWatabe, H., Furuhama, T., Tani‐Ishii, N., & Mikuni‐Takagaki, Y. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.07.015 · Cited by 126
The role of Snail in prostate cancer
Smith, B., & Odero-Marah, V. (2012) · Cell Adhesion & Migration · doi:10.4161/cam.21687 · Cited by 125 · cited 1×
“Collagen is also involved in promoting the mesenchymal phenotype, with collagen type I upregulating Slug and Snail expression, and downregulating E-cadherin expression, in ovarian and prostate cancer cell lines [112].”
BackgroundDong, Y., Xie, X., Wang, Z., Hu, C., Zheng, Q., Wang, Y., Chen, R., Xue, T., Chen, J., Gao, D., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.01.079 · Cited by 122 · cited 1×
“The fibrotic stroma is further maintained, leading to upregulation of VEGF, and therefore the upregulation of angiogenesis [241].”
BackgroundSenescent stroma promotes prostate cancer progression: The role of miR‐210
Taddei, M. L., Cavallini, L., Comito, G., Giannoni, E., Folini, M., Marini, A., Gandellini, P., Morandi, A., Pintus, G., Raspollini, M. R., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.07.009 · Cited by 119 · cited 1×
“The hypoxia-associated miR-210 is a driving factor for this transformation [215], in addition to TGF-β in the stroma, which is secreted by cancer cells following hypoxia [216].”
BackgroundRegulations of P-Glycoprotein/ABCB1/MDR1in Human Cancer Cells
Katayama, K., Noguchi, K., & Sugimoto, Y. (2014) · New Journal of Science · doi:10.1155/2014/476974 · Cited by 118 · cited 1×
“For example, the PI3K/Akt and Wnt/β-catenin pathways have been associated with regulating transcription of the MDR1 gene [139], as well as being responsive to mechanical stimuli [140,141].”
BackgroundMouse Snail Is a Target Gene for HIF
Luo, D., Wang, J., Li, J., & Post, M. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0214 · Cited by 116 · cited 15×
“HIF-1α binds to the hypoxia response element (HRE) of many genes, and this element has been identified in the promoters for Twist [84], Snail [85], and ZEB-1 [86].”
BackgroundInfluentialYeo, C. D., Kang, N., Choi, S. Y., Kim, B. N., Park, C. K., Kim, J. W., Kim, Y. K., & Kim, S. J. (2017) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2016.302 · Cited by 116
Extracellular matrix and HIF‐1 signaling: The role of prolidase
Surazynski, A., Donald, S. P., Cooper, S. K., Whiteside, M. A., Salnikow, K., Liu, Y., & Phang, J. M. (2008) · International Journal of Cancer · doi:10.1002/ijc.23263 · Cited by 114 · cited 1×
“Additionally, a study has shown that a collagen degradation enzyme present in fibrosis, prolidase, can promote HIF-1α activity [229].”
BackgroundLee, K., Chen, Q. K., Lui, C., Cichon, M. A., Radisky, D. C., & Nelson, C. M. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-02-0166 · Cited by 112 · cited 1×
“In a separate mechanism in breast cancer cells, the protein Rac1b localizes to the plasma membrane on stiff substrates, and this event promotes Snail expression by facilitating the production of reactive oxygen species by NADPH oxidase [145].”
BackgroundDeying, W., Feng, G., Shumei, L., Zhao, H., Liu, M., & Hongqing, W. (2017) · Bioscience Reports · doi:10.1042/bsr20160470 · Cited by 111 · cited 1×
“HGF is also highly secreted from CAFs, and it promotes oncogenic PI3K/Akt signaling in ovarian cancer cells [178].”
BackgroundTumor interstitial fluid pressure as an early-response marker for anticancer therapeutics
Ferretti, S., Allegrini, P. R., Becquet, M. M., & McSheehy, P. M. J. (2009) · Neoplasia · doi:10.1593/neo.09554 · Cited by 106 · cited 1×
“The loss of interstitial fluid pressure with therapy has been observed as a possible marker for therapy response [71].”
BackgroundHofmann, M., Guschel, M., Bernd, A., Bereiter-Hahn, J., Kaufmann, R., Tandi, C., Wiig, H., & Kippenberger, S. (2006) · Neoplasia · doi:10.1593/neo.05469 · Cited by 106 · cited 1×
“The mechanical stretch induced by IFP has been shown to promote proliferation through MAPK in a xenograft tumor model [200].”
BackgroundWu, Y.-H., Chang, T.-H., Huang, Y.-F., Chen, C.-C., & Chou, C.-Y. (2015) · Oncotarget · doi:10.18632/oncotarget.4250 · Cited by 105 · cited 1×
“Collagen I has been shown to promote MAPK activation in hepatocellular carcinoma cells [124], and to promote chemoresistance in ovarian cancer cells through the activation of Akt and pyruvate dehydrogenase kinase 1 (PDK1) [125].”
BackgroundSubstrate Rigidity Controls Activation and Durotaxis in Pancreatic Stellate Cells
Lachowski, D., Cortes, E., Pink, D., Chronopoulos, A., Karim, S. A., P. Morton, J., & del Río Hernández, A. E. (2017) · Scientific Reports · doi:10.1038/s41598-017-02689-x · Cited by 105 · cited 1×
“As cells accumulate in this fibrotic region, and become activated by mechanotransduction, rigidity is further increased by the ECM remodeling activity of these cells [54,225].”
BackgroundSelf-citationObacz, J., Pastoreková, S., Vojtesek, B., & Hrstka, R. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-93 · Cited by 105 · cited 1×
“Pro-survival pathways are also induced through HIF-1α-induced modulation of the expression of VEGF and the cell cycle protein p21WAF1 [102].”
BackgroundCancer Associated Fibroblasts and Tumor Growth: Focus on Multiple Myeloma
Veirman, K. D., Rao, L., Bruyne, E. D., Menu, E., Valckenborgh, E. V., Riet, I. V., Frassanito, M. A., Marzo, L. D., Vacca, A., & Vanderkerken, K. (2014) · Cancers · doi:10.3390/cancers6031363 · Cited by 102 · cited 3×
“TGF-β is one of these factors, and it also promotes the expression of other angiogenic factors (FGF, VEGF, CXCL12 and PDGF-C) in endothelial cells [234,235].”
BackgroundPiotrowski-Daspit, A. S., Tien, J., & Nelson, C. M. (2016) · Integrative Biology · doi:10.1039/c5ib00282f · Cited by 101 · cited 1×
“, invasion into the stroma as a group of adhered cells [190].”
BackgroundSada, M., Ohuchida, K., Horioka, K., Okumura, T., Moriyama, T., Miyasaka, Y., Ohtsuka, T., Mizumoto, K., Oda, Y., & Nakamura, M. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.01.016 · Cited by 101 · cited 1×
“This hypoxia-induced regulation has also been observed in fibroblasts [206,207].”
BackgroundLaminins 411 and 421 differentially promote tumor cell migration via α6β1 integrin and MCAM (CD146)
Ishikawa, T., Wondimu, Z., Oikawa, Y., Gentilcore, G., Kiessling, R. W., Brage, S. E., Hansson, J., & Patarroyo, M. E. (2014) · Matrix Biology · doi:10.1016/j.matbio.2014.06.002 · Cited by 100
Han, Z., Feng, J., Hong, Z., Chen, L., Li, W., Liao, S., Wang, X., Ji, T., Wang, S., Ma, D., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.04.087 · Cited by 99 · cited 1×
“Increased levels of phosphorylated STAT3 are associated with chemoresistance in ovarian cancer cells, with STAT3 knockdown facilitating apoptosis induced by cisplatin [34].”
Background
Cited by
Emran, T. B., Shahriar, A., Mahmud, A. R., Rahman, T., Abir, M. H., Siddiquee, M. F. R., Ahmed, H., Rahman, N., Nainu, F., Wahyudin, E., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.891652 · Cited by 606
“MDRmay develop due to oncogene mutations, changes in the tumor microenvironment (TME), tumor heterogeneity, target site mutations, or epigenetic changes (33, 34) (Figure 1).”
BackgroundA Forward Vision for Chemodynamic Therapy: Issues and Opportunities
Zhao, P., Li, H., & Bu, W. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202210415 · Cited by 308
Cancer-associated fibroblasts-derived IL-8 mediates resistance to cisplatin in human gastric cancer
Zhai, J., Shen, J., Xie, G., Wu, J., He, M., Gao, L., Zhang, Y., Yao, X., & Shen, L. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.04.002 · Cited by 272
Guerini, A. E., Triggiani, L., Maddalo, M., Bonù, M. L., Frassine, F., Baiguini, A., Alghisi, A., Tomasini, D., Borghetti, P., Pasinetti, N., et al. (2019) · Cancers · doi:10.3390/cancers11091284 · Cited by 146
Role of Wnt/β‐Catenin Signaling in the Chemoresistance Modulation of Colorectal Cancer
Yuan, S., Tao, F., Zhang, X., Zhang, Y., Sun, X., & Wu, D. (2020) · BioMed Research International · doi:10.1155/2020/9390878 · Cited by 131
“As the main component of the stroma, cancer-associated fibroblasts (CAFs), different from normal fibroblasts in the TME, exert inherent support on cancer cells via secretion of molecular messengers and cell-to-cell contact [74].”
Background
Metadata
- Authors
- Yeldag, G., Rice, A., & Del Río Hernández, A.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2018-11-28
- Volume
- 10
- Issue
- 12
- Pages
- 471
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W2902854367
- Cited by
- 214
- References
- 245
- FWCI
- 6.74
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.